Recombinant PRV Expressing GP3 and GP5 of PRRSV Provides Effective Protection Against Coinfection With PRV and PRRSV
Transboundary and Emerging Diseases · 2025-01 · 2025 (1)
DOI: 10.1155/tbed/4612568 ↗Kurz gefasst
Fachartikel in der Zeitschrift Transboundary and Emerging Diseases, online erschienen am 08.05.2025. Verfasst von Ruhai Guo und 12 weiteren Autor:innen. Beteiligte Einrichtung: College of Veterinary Medicine, Northwest A&F University, Yangling, Shaanxi, China. Hauptthemen laut MEDLINE: Porcine respiratory and reproductive syndrome virus, Porcine Reproductive and Respiratory Syndrome, Herpesvirus 1, Suid, Pseudorabies. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Porcine Reproductive and Respiratory Syndrome (PRRS) and Pseudorabies (PR) are highly contagious diseases caused by Porcine Reproductive and Respiratory Syndrome virus (PRRSV) and Pseudorabies virus (PRV). Due to the limited protective ability of currently commercialized vaccines against NADC30‐like PRRSV and PRV variants, the pathological damage caused by coinfection of these two viruses has a significant impact on China’s pig farming industry. In this study, six recombinant PRV stains with TK and gI/gE deletions and fused expression of GM‐CSF and GP3 and GP5 proteins from NADC30‐Like PRRSV were constructed by using the HDR‐CRISPR/Cas9 D10A system. After assessing growth characteristics and genetic stability, four strains demonstrating stable proliferation and expression of the GM‐CSF, GP3, GP5 fusion protein in BHK‐21 cells were selected. Evaluation of their ability to induce specific humoral and cellular immune responses in mice led to the selection of two strains with superior immunogenic effects: rPRV‐ΔTK‐GP3‐GP5‐eGFP‐ΔgI/gE‐mCHERRY‐B and rPRV‐ΔTK‐eGFP‐ΔgI/gE‐GP3‐GP5‐mCHERRY‐B. These strains were found to enhance NADC30‐like PRRSV and PRV‐specific immune responses in piglets, reduce pathological damage, and accelerate symptom resolution. In general, PRV is a promising viral vector for expressing PRRSV genes, and the data from this study provides references for new candidate vaccines against PRRSV.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Veterinary Medicine, Northwest A&F University, Yangling, Shaanxi, China.
- Faculty of Sustainable Agriculture, Universiti Malaysia Sabah, Sandakan, Sabah, Malaysia.
- Department of Life Science, Nanjing Xiaozhuang University, Nanjing, Jiangsu, China.
- School of Animal Science and Technology, Foshan University, Foshan, Guangdong, China.
ORCID-Profile: Ruhai Guo, Hui Li, Honglin Xie, Xinglong Wang
Zitieren
APA
Guo, R., Li, H., Li, J., Qv, J., Ren, G., Zhang, X., Nasir, S., Zhang, J., Luo, C., Zeshan, B., Zhou, Y., Xie, H., & Wang, X. (2025). Recombinant PRV Expressing GP3 and GP5 of PRRSV Provides Effective Protection Against Coinfection With PRV and PRRSV. Transboundary and Emerging Diseases, 2025(1). https://doi.org/10.1155/tbed/4612568
Vancouver
Guo R, Li H, Li J, Qv J, Ren G, Zhang X, et al. Recombinant PRV Expressing GP3 and GP5 of PRRSV Provides Effective Protection Against Coinfection With PRV and PRRSV. Transboundary and Emerging Diseases. 2025;2025(1). doi:10.1155/tbed/4612568
BibTeX
@article{Guo2025,
author = {Guo, Ruhai and Li, Hui and Li, Junda and Qv, Jahao and Ren, Guofan and Zhang, Xiao and Nasir, Saba and Zhang, Jingnan and Luo, Chen and Zeshan, Basit and Zhou, Yefei and Xie, Honglin and Wang, Xinglong},
title = {Recombinant PRV Expressing GP3 and GP5 of PRRSV Provides Effective Protection Against Coinfection With PRV and PRRSV},
journal = {Transboundary and Emerging Diseases},
year = {2025},
volume = {2025},
number = {1},
doi = {10.1155/tbed/4612568}
}
EUVIMED